Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CHRS compared with KLRS: revenue, margins and what each company keeps, and the suppliers and customers both name
CHRS
Coherus Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
KLRS
Kalaris Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CHRS
Coherus Oncology, Inc.
vs
KLRS
Kalaris Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
CHRS
with
KLRS
No shared trading history for CHRS and KLRS.
Shared co-movers: not yet measured (KLRS).
CHRS, solid
KLRS, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
CHRS
Coherus Oncology, Inc.
Change
0.87
▲
+5.32%
· post 0.77
Mkt cap
$115.8M
Revenue
$14M
Q2 FY26
Revenue
$42M
FY25
KLRS
Kalaris Therapeutics, Inc.
Change
2.00
▼
−1.48%
· post 2.06
Closed
Nov 2 '26
Mkt cap
$48.3M
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 2 '26
CHRS
Coherus Oncology, Inc.
vs
KLRS
Kalaris Therapeutics, Inc.
0.87
▲
+5.32%
post 0.77
Price
2.00
▼
−1.48%
post 2.06
$115.8M
Mkt cap
$48.3M
Q2 FY26
$14M
Revenue
—
FY25
$42M
Revenue
—
Change
Change
CHRS
0.87
▲
+5.32%
vs
KLRS
2.00
▼
−1.48%
Closed
Nov 2 '26